Brain plasticity in paediatric neurology

European Journal of Paediatric Neurology

Volumn 7, Issue 3, 2003, Pages 105-113

  Johnston, Michael V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fragile X syndrome; Glutamate; Mental retardation; Neurofibromatosis; Plasticity; Rett syndrome

Indexed keywords

GLUTAMATE RECEPTOR; LEAD; SYNAPSE RECEPTOR;

BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CELL NUCLEUS; CHILD; CHILDHOOD DISEASE; CYTOSKELETON; DENDRITE; EPILEPSY; FRAGILE X SYNDROME; HUMAN; LEAD POISONING; LEARNING; MEMORY; MENTAL DEFICIENCY; MENTAL RETARDATION MALFORMATION SYNDROME; MOLECULAR BIOLOGY; NERVE CELL PLASTICITY; NERVE FIBER; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038540599     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3798(03)00039-4     Document Type: Review

References (74)

1. Buonomano DV, Merzenich MM. Cortical plasticity: from synapses to maps. Annu Rev Neurosci 1998;21:149-86.
2. Wall JT, Xu J, Wang X. Human brain plasticity: an emerging view of the multiple substrates and mechanisms that cause cortical changes and related sensory dysfunctions after injuries of sensory inputs from the body. Brain Res Rev 2002;39:181-215.
3. Johnston MV, Nishimura A, Harum K, et al. Sculpting the developing brain. Adv Pediat 2001;48:1-38.
4. Elbert T, Pantev C, Wienbruch C, et al. Increased cortical representation of the fingers of the left hand in string players. Science 1995;270:305-7.
5. Sadato N, Pascual-Leone A, Grafman J, et al. Neural networks for Braille reading by the blind. Brain 1998;121:1213-29.
6. Hertz-Pannier L, Chiron C, Jambaque I, et al. Late plasticity for language in a child's non-dominant hemisphere, A pre- and post-surgery fMRI study Brain 2002;125:361-72.
7. Boatman D, Freeman J, Vining E, et al. Language recovery after left hemispherectomy in children with late-onset seizures. Ann Neurol 1999;46:579-86.
8. Raff MC, Barres BA, Burne JF, et al. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 1993;262:695-700.
9. Faverjon S, Silveira DC, Fu DD. Beneficial effects of enriched environment following status epilepticus in immature rats. Neurology 2002;59:1356-64.
10. Heeger DJ, Huk AC, Geisler WS, et al. Spikes versus BOLD: What does neuroimaging tell us about neuronal activity? Nat Neurosci 2000;3:631-3.
11. Sibson NR, Dhankhar A, Mason GF, et al. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 1998;95:316-21.
12. Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res 1999;24:321-9.
13. Pons TP, Garraghty PE, Ommaya AK, et al. Massive cortical reorganization after sensory deafferentation in adult macaques. Science 1991;252:1857-60.
14. Huttenlocher PR. Morphometric study of human cerebral cortex development. Neuropsychologia 1990;28:517-27.
15. Rakic P, Bourgeois JP, Eckenhoff MF, et al. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 1986;232: 232-5.
16. Chugani HT. Metabolic imaging: A window on brain development and plasticity. Neuroscientist 1999;5: 29-40.
17. Vaegan Taylor D. Critical period for deprivation amblyopia in children. Trans Ophthalmol Soc UK 1979;99:432-9.
18. Penn AA, Shatz CJ. Brain waves and brain wiring: the role of endogenous and sensory-driven neural activity in development. Pediatr Res 1999;45:447-58.
19. Cohen-Cory S. The developing synapse: construction and modulation of synaptic structures and circuits. Science 2002;298:770-6.
20. Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioral memory. Nat Rev Neurosci 2002;3:175-90.
21. Kovalchuk Y, Hanse E, Kafitz KW, Konnerth A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science 2002;295:1729-34.
22. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001;294:1030-8.
23. Malenka RC, Nicoll RA. Long-term potentiation: a decade of progress? Science 1999;285:1870-4.
24. Malinow R, Malenka. RC. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002;25:103-26.
25. Crair MC, Malenka RC. A critical period for long-term potentiation at thalamocortical synapses. Nature 1995;375:325-8.
26. McDonald JW, Johnston MV, Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15:41-70.
27. Sheng M, Kim MJ. Postsynaptic signaling and plasticity mechanisms. Science 2002;298:776-80.
28. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal transduction integration system subserving synaptic plasticity and memory. J Neurochem 2001;76:1-10.
29. Trachtenberg JT, Chen BE, Knott GW, et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002;420: 788-94.
30. Jepsen K, Rosenfeld NG. Biological roles and mechanistic action of co-repressor complexes. J Cell Sci 2002;115:689-98.
31. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet 1999;23:185-8.
32. Johnston MV, Jeon OH, Pevsner J, et al. Neurobiology of Rett syndrome: a genetic disorder of synaptic devlopment. Brain Dev 2001;23:S206-13.
33. Trivier E, De Cesare D, Jacquot S, et al. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 1996;384:567-70.
34. Harum KH, Alemi L, Johnston MV. Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. Neurology 2001;56: 207-14.
35. Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by mutions in the transcriptional coactivator CBP. Nature 1995;376:348-51.
36. Nucifora FC, Sasaki M, Peters MF, et al. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leding to cellular toxicity. Science 2001;291:2423-8.
37. Picketts DJ, Higgs DR, Bachoo S, et al. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet 1996;5:1899-907.
38. Barnes AP, Milgram SL. Signals from the X: signal transduction and X-linked mental retardation. Int J Devl Neurosci 2002;20:397-406.
39. Weeber EJ, Sweatt JD. Molecular neurobiology of human cognition. Neuron 2002;33:845-8.
40. Ozonoff S. Cognitive impairment in neurofibromatosis 1. Am J Med Genet 1999;89:45-52.
41. Costa RM, Federov NB, Kogan JH, et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis 1. Nature 2002;415:526-30.
42. Nellist M, van Slegtenhorst MA, Goedbloed M, et al. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem 1999;274:35647-52.
43. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420:629-35.
44. Ramakers GJA. Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci 2002;25:191-9.
45. Billuart P, Bienvenu T, Ronce N, et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998;392:923-6.
46. Pateris NG, Buckler J, Cadle AB, Gorski JL. Genomic organization of the faciogenital dysplasia (FDG1; Aarskog syndrome) gene. Genomics 1997;43:390-4.
47. Zemni R, Bienvenu T, Vinet MC, et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nature Genet 2000;24:167-70.
48. Todd PK, Malter JS. Fragile X mental retardation protein in plasticity and disease. J Neurosci Res 2002;70:623-30.
49. Comery TA, Harris JB, Willems PJ, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 1997;94:5401-4.
50. Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 2002;99:7746-50.
51. Li J, Pelletier MR, Velazquez J-LP, Carlen PL. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci 2002;19:138-51.
52. Needleman HL, Schell A, Bellinger D, et al. The long term effects of exposure to low doses of lead in childhood. An 11 year followup report. N Engl J Med 1990;322:83-8.
53. Bouton CM, Frelin LP, Forde CE, et al. Synaptotagmin I is a molecular target of lead. J Neurochem 2001;76:1724-35.
54. Lasley SM, Gilbert ME. Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chornic lead exposure level. Toxicol Sci 2002;66:139-47.
55. +) exposure alters NMDA subtypes and reduces CREB phosphorylation in rat brain. Brain Res Dev Brain Res 2002;139:217-26.
56. Lasley SM, Green MC, Gilbert ME. Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol Teratol 2001; 23:185-9.
57. Kim KA, Chakraborti T, Goldstein G, et al. Exposure of lead elevates induction of zif268 and Arc mRNA in rats after electroconvulsive shock: the involvement of PKC. J Neurosci Res 2002;69:268-77.
58. Wilson MA, Johnston MV, Goldstein GW, Blue ME. Neonatal lead exposure impairs development of rodent barrel field cortex. Proc Natl Acad Sci USA 2000;97:5540-5.
59. Cline HT, Witte S, Jones KW. Low lead levels stunt neuronal growth in a reversible fashion. Proc Natl Acad Sci USA 1996;93:9915-20.
60. Guilarte TR, Toscano CD, McGlothan JL, Weaver SA. Environmental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure. Ann Neurol 2003;53:50-6.
61. Holmes GL, Ben-Ari Y. Seizures in the developing brain: perhaps not so benign after all. Neuron 1998;21:1231-4.
62. Sutula TP. Secondary epileptogenesis, kindling and intractable epilepsy: a reappraisal from the perspective of neural plasticity. Int Rev Neurobiol 2001;45:355-86.
63. Ribak CE, Dashtipour K. Neuroplasticity in the damaged dentate gyrus of the epileptic brain. Prog Brain Res 2002;136:319-28.
64. Rutten A, van Albada M, Silveira DC, et al. Memory impairment following status epilepticus in immature rats: time-course and environmental effects. Eur J Neurosci 2002;16:501-13.
65. Hosford DA, Crain BJ, Cao Z, et al. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus. J Neurosci 1991;11:428-34.
66. McDonald JW, Garofalo EA, Hood T, et al. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1991;29:529-41.
67. Blumcke I, Beck H, Scheffler B, et al. Altered distribution of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit GluR2(4) and the N-methyl-D-aspartate receptor subunit NMDAR1 in the hippocampus of patients with temporal lobe epilepsy. Acta Neuropathol 1996; 92:576-87.
68. Grigorenko E, Glazier S, Bell W, et al. Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy. J Neurol Sci 1997;153:35-45.
69. Mathern GW, Pretorius JK, Kornblum HI, et al. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain 1997;120:1937-59.
70. 3H]Flumazenil autoradiography in hippocampal sclerosis. Ann Neurol 1998;43:618-26.
71. Johnston MV, Trescher WH, Ishida A, Nakajima W. Neurobiology of hypoxic- ischemic injury in the immature brain. Pediatric Research 2001;49:735-41.
72. Johnston MV, Nakajima W, Hagberg H. Mechanisms of hypoxic neurodegeneration in the developing brain. Neurosci 2002;8:212-20.
73. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-41.
74. Johnston MV, Hudson C. Effets of postnatal hypoxia-ischemia on cholinergic neurons in the developing rat forebrain: choline acetyltransferase immunocytochemistry. Develop Brain Res 1987;34: 41-50.